THE BUSINESS OF PHARMACOGENOMICS - CONSIDERED THE HEIR APPARENT TO FUNCTIONAL GENOMICS, PHARMACOGENOMICS PROMISES TO REDEFINE BASIC NOTIONSOF WHAT CONSTITUTES A DISEASE
A. Persidis, THE BUSINESS OF PHARMACOGENOMICS - CONSIDERED THE HEIR APPARENT TO FUNCTIONAL GENOMICS, PHARMACOGENOMICS PROMISES TO REDEFINE BASIC NOTIONSOF WHAT CONSTITUTES A DISEASE, Nature biotechnology, 16(2), 1998, pp. 209-210